Karah Herdman Parschauer Insider Trading $RARE Ultragenyx Pharmaceutical Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karah Herdman Parschauer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karah Herdman Parschauer. Karah Herdman Parschauer is EVP and General Counsel in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Evolus, Inc. ($EOLS) and Director in Arcturus Therapeutics Holdings Inc. ($ARCT).
Karah Herdman Parschauer in Ultragenyx Pharmaceutical Inc.
Trading Symbol: RAREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karah Herdman Parschauer: EVP and General Counsel
Holdings: 29,997 shares
Current Value: $2,187,081
Latest Transaction: May 10 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Karah Herdman Parschauer in Ultragenyx Pharmaceutical Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARCT, EOLS, RARE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 113.67 | 313 | 35,579 | 29,997 | 30.3 K to 30 K (-1.03 %) |
Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | A | 142.47 | 11,000 | 1,567,170 | 11,000 | |
Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 138.17 | 3,970 | 548,535 | 30,227 | 34.2 K to 30.2 K (-11.61 %) |
Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 4,636 | 0 | 34,197 | 29.6 K to 34.2 K (+15.68 %) |
Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 5,500 | 0 | 29,561 | 24.1 K to 29.6 K (+22.86 %) |
Nov 02 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 54.50 | 9,903 | 539,714 | 25,000 | |
Nov 02 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 100.12 | 9,903 | 991,488 | 24,061 | 34 K to 24.1 K (-29.16 %) |
Nov 02 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Buy | M | 54.50 | 9,903 | 539,714 | 33,871 | 24 K to 33.9 K (+41.32 %) |
Oct 30 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 54.50 | 97 | 5,287 | 34,903 | |
Oct 30 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 100.00 | 97 | 9,700 | 23,968 | 24.1 K to 24 K (-0.40 %) |
Oct 30 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Buy | M | 54.50 | 97 | 5,287 | 24,065 | 24 K to 24.1 K (+0.40 %) |
Oct 16 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 88.00 | 325 | 28,600 | 23,968 | 24.3 K to 24 K (-1.34 %) |
Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 54.50 | 10,000 | 545,000 | 35,000 | |
Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 95.00 | 10,000 | 950,000 | 24,293 | 34.3 K to 24.3 K (-29.16 %) |
Oct 13 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Buy | M | 54.50 | 10,000 | 545,000 | 34,293 | 24.3 K to 34.3 K (+41.16 %) |
Oct 07 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 48.43 | 10,000 | 484,300 | 17,000 | |
Oct 07 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 90.00 | 10,000 | 900,000 | 24,293 | 34.3 K to 24.3 K (-29.16 %) |
Oct 07 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Buy | M | 48.43 | 10,000 | 484,300 | 34,293 | 24.3 K to 34.3 K (+41.16 %) |
Sep 24 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 48.43 | 10,000 | 484,300 | 27,000 | |
Sep 24 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 85.00 | 10,000 | 850,000 | 24,293 | 34.3 K to 24.3 K (-29.16 %) |
Sep 24 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Buy | M | 48.43 | 10,000 | 484,300 | 34,293 | 24.3 K to 34.3 K (+41.16 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 54.50 | 10,000 | 545,000 | 45,000 | |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 88.39 | 2,370 | 209,484 | 24,293 | 26.7 K to 24.3 K (-8.89 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 88.44 | 10,000 | 884,400 | 26,663 | 36.7 K to 26.7 K (-27.28 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Buy | M | 54.50 | 10,000 | 545,000 | 36,663 | 26.7 K to 36.7 K (+37.51 %) |
Jun 22 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 78.22 | 649 | 50,765 | 26,663 | 27.3 K to 26.7 K (-2.38 %) |
May 19 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 74.72 | 2,722 | 203,374 | 27,312 | 30 K to 27.3 K (-9.06 %) |
May 08 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 66.26 | 248 | 16,432 | 29,904 | 30.2 K to 29.9 K (-0.82 %) |
Apr 21 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 58.57 | 248 | 14,525 | 30,152 | 30.4 K to 30.2 K (-0.82 %) |
Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | A | 56.08 | 22,000 | 1,233,760 | 22,000 | |
Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 56.08 | 2,118 | 118,777 | 30,400 | 32.5 K to 30.4 K (-6.51 %) |
Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 5,634 | 0 | 32,518 | 26.9 K to 32.5 K (+20.96 %) |
Mar 03 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 7,800 | 0 | 26,884 | 19.1 K to 26.9 K (+40.87 %) |
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 1,434 | 0 | 19,084 | 17.7 K to 19.1 K (+8.12 %) |
Jun 24 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 61.50 | 1,226 | 75,399 | 17,650 | 18.9 K to 17.7 K (-6.50 %) |
Jun 24 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 63.01 | 1,489 | 93,822 | 18,876 | 20.4 K to 18.9 K (-7.31 %) |
Jun 24 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 63.48 | 649 | 41,199 | 20,365 | 21 K to 20.4 K (-3.09 %) |
Jun 24 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 61.50 | 1,226 | 75,399 | 17,650 | 18.9 K to 17.7 K (-6.50 %) |
Jun 24 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 63.01 | 1,489 | 93,822 | 18,876 | 20.4 K to 18.9 K (-7.31 %) |
Jun 24 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 63.48 | 649 | 41,199 | 20,365 | 21 K to 20.4 K (-3.09 %) |
May 07 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 1,434 | 0 | 21,014 | 19.6 K to 21 K (+7.32 %) |
Apr 30 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 68.30 | 468 | 31,964 | 19,580 | 20 K to 19.6 K (-2.33 %) |
Apr 23 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 64.43 | 248 | 15,979 | 20,048 | 20.3 K to 20 K (-1.22 %) |
Aug 21 2018 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 78.53 | 5,000 | 392,650 | 9,181 | 14.2 K to 9.2 K (-35.26 %) |
Jun 21 2018 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 82.77 | 1,226 | 101,476 | 14,181 | 15.4 K to 14.2 K (-7.96 %) |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 85.31 | 649 | 55,366 | 15,407 | 16.1 K to 15.4 K (-4.04 %) |
May 10 2018 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 60.00 | 1,465 | 87,900 | 16,056 | 17.5 K to 16.1 K (-8.36 %) |
Apr 19 2018 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 1,431 | 0 | 17,521 | 16.1 K to 17.5 K (+8.89 %) |
Jun 21 2017 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 63.38 | 705 | 44,683 | 8,795 | 9.5 K to 8.8 K (-7.42 %) |
Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | A | 88.80 | 12,000 | 1,065,600 | 12,000 | |
Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 2,000 | 0 | 9,500 | 7.5 K to 9.5 K (+26.67 %) |
Jun 22 2016 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | A | 54.50 | 60,000 | 3,270,000 | 60,000 | |
Jun 22 2016 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Page: 1